All Stories

  1. Evaluation of Real-World Safety Surveillance of Targeted Immune-Modifying Therapies Across Immune-Mediated Inflammatory Diseases Using the “Medicines in Acute and Chronic Care in Scotland” Linked Data infrastructure: A Study Protocol and Feasibility As...

    Article • March 2026, JMIR Publications Inc.

    Amanj Kurdi

  2. Data Resource profile: Medicines in Acute and Chronic Care in Scotland (MACCS)

    Article • March 2026, openRxiv

    Amanj Kurdi

  3. Multicentre Surveillance of Antimicrobial Resistance in Iraq: Implications for National Stewardship Policy and WHO AWaRe–Aligned Public Health Strategies (Preprint)

    Article • March 2026, JMIR Publications Inc.

    Amanj Kurdi

  4. Data Resource Profile: Public Health Scotland (PHS) Homecare Medicines Dataset: A National Resource for Linked Prescribing Data for Specialist Medicines Prescribed in Hospital Outpatient setting and Supplied Via Homecare Services

    Article • International Journal for Population Data Science, February 2026, Swansea University

    Amanj Kurdi

  5. Developing AWaRe-ness in primary care across low- and middle-income countries – a vital challenge for antibiotic stewardship programs

    Article • Expert Review of Anti-infective Therapy, February 2026, Taylor & Francis

    Amanj Kurdi

  6. Health service contacts for mental health and substance use on release from prison: a retrospective population-based data linkage study

    Article • BMJ Open, February 2026, BMJ

    Amanj Kurdi

  7. Challenges regarding the provision of antibiotics via the informal sector across low- and middle-income countries and potential ways forward

    Article • Journal of the Medical College for Women & Hospital, January 2026, Bangladesh Journals Online (BanglaJOL)

    Amanj Kurdi

  8. Data Resource Profile: The Scottish Combined Medicines Dataset (SCoMeD)

    Article • International Journal for Population Data Science, January 2026, Swansea University

    Amanj Kurdi

  9. Pregnancy, baby, and childhood outcomes from using anti-seizure medication during pregnancy

    Article • Communications Medicine, December 2025, Springer Science + Business Media

    Amanj Kurdi

  10. Prevalence and Associated Factors for Purchasing Antibiotics Without a Prescription Among Patients in Rural South Africa: Implications for Addressing Antimicrobial Resistance

    Article • Antibiotics, December 2025, MDPI AG

    Amanj Kurdi

  11. Study protocol for optimising antipsychotic prescribing among hospitalised patients in the acute care setting in Scotland: a national retrospective cohort study

    Article • BMJ Open, December 2025, BMJ

    Amanj Kurdi

  12. CO252 Tocilizumab vs. Sarilumab Among Adults Hospitalized Due to COVID-19: A Federated Comparative Effectiveness Study Across England and Scotland Under the Target Trial Emulation Framework

    Article • Value in Health, December 2025, Elsevier

    Amanj Kurdi

  13. Impact of gabapentinoids’ reclassification policy and COVID-19 on gabapentinoids’ utilization pattern and their associated mortality in Scotland and Northern Ireland: a segmental regression analysis

    Article • Expert Review of Clinical Pharmacology, November 2025, Taylor & Francis

    Amanj Kurdi

  14. A comprehensive systematic review of the types of medication classes targeted by deprescribing tools and the tools/interventions applied to each class

    Article • Expert Review of Clinical Pharmacology, November 2025, Taylor & Francis

    Amanj Kurdi

  15. Clinical Decision Support (CDS) tools for Medicine Optimisation in Hospitals

    Article • Research in Social and Administrative Pharmacy, November 2025, Elsevier

    Amanj Kurdi

  16. Co-design and development of a community pharmacy-based CVD risk screening service in Saudi Arabia: A Multi-stakeholders Nominal Group Technique (NGT) Consensus method.

    Article • Research in Social and Administrative Pharmacy, November 2025, Elsevier

    Amanj Kurdi

  17. Knowledge Gaps influencing Inappropriate Surgical Antibiotic Prophylaxis Prescribing in Kuwait: Qualitative Study

    Article • Research in Social and Administrative Pharmacy, November 2025, Elsevier

    Amanj Kurdi

  18. Utilisation patterns and quality of lipid control among patients prescribed lipid-lowering therapies in primary care settings in Kuwait: a nationwide cross-sectional study

    Article • Research in Social and Administrative Pharmacy, November 2025, Elsevier

    Amanj Kurdi

  19. Utilisation trends of lipid lowering therapies between 2017 and 2022 and lipid target attainment among patients receiving proprotein convertase subtilisin-kexin type 9 inhibitors at a specialised tertiary hospital

    Article • Research in Social and Administrative Pharmacy, November 2025, Elsevier

    Amanj Kurdi

  20. Effectiveness of deprescribing tools and interventions in detecting and deprescribing potentially inappropriate medications and their effect on patients’ clinical outcomes: A systematic review

    Article • Research in Social and Administrative Pharmacy, November 2025, Elsevier

    Amanj Kurdi

  21. Types of potentially inappropriate medications (PIMs) classes targeted by deprescribing tools and interventions: A systematic review

    Article • Research in Social and Administrative Pharmacy, November 2025, Elsevier

    Amanj Kurdi

  22. Guest Editorial

    Article • SA Pharmaceutical Journal, November 2025, Medpharm Publications

    Amanj Kurdi

  23. Access to services for mental ill-health and substance use among people released from prison in Scotland (RELEASE): Retrospective observational cohort study protocol

    Article • International Journal for Population Data Science, October 2025, Swansea University

    Amanj Kurdi

  24. Tocilizumab versus sarilumab among adults hospitalised with COVID-19: target trial emulation across England and Scotland

    Article • October 2025, Springer Science + Business Media

    Amanj Kurdi

  25. A Simulated Client Study on Non-Prescription Antibiotic Sales and Counselling Practices in Iraqi Nurse-Led Clinics: Implications for Antimicrobial Resistance

    Article • Infection and Drug Resistance, October 2025, Taylor & Francis

    Amanj Kurdi

  26. Post-imprisonment healthcare contacts for mental health and substance use: A Scottish cohort study

    Article • European Journal of Public Health, October 2025, Oxford University Press (OUP)

    Amanj Kurdi

  27. BNT162b2 COVID-19 vaccination uptake, safety, effectiveness, and waning in children and young people aged 5–11 years in Scotland

    Article • Journal of Global Health, August 2025, Edinburgh University Global Health Society

    Amanj Kurdi

  28. Introduction of Biopharmaceuticals in Europe: A Cross-Sectional Study of Early Diffusion Patterns and Data Availability

    Article • BioDrugs, August 2025, Springer Science + Business Media

    Amanj Kurdi

  29. Prescribing pattern of disease-modifying antirheumatic drugs in Scotland (2019–2023): a population-based retrospective cohort study

    Article • Expert Review of Clinical Pharmacology, August 2025, Taylor & Francis

    Amanj Kurdi

  30. Evaluation of Age-Related Changes in Human Lens Stiffness Through a Novel Non-Invasive Method Using Shear Wave Ultrasound Elastography

    Article • Current Eye Research, July 2025, Taylor & Francis

    Amanj Kurdi

  31. A scoping review of factors associated with the prescribing choice of direct oral anticoagulant drugs

    Article • Expert Review of Cardiovascular Therapy, July 2025, Taylor & Francis

    Amanj Kurdi

  32. Impact of the COVID-19 pandemic on antidepressant use in eleven European regions: a comparative time series analysis 2018–2022

    Article • Social Psychiatry and Psychiatric Epidemiology, July 2025, Springer Science + Business Media

    Amanj Kurdi

  33. Anti-seizure medication in pregnancy and pregnancy, baby, and child outcomes: a population-based cohort study

    Article • June 2025, Springer Science + Business Media

    Amanj Kurdi

  34. A survey on Clostridioides difficile infection (CDI) testing in microbiology laboratories in Saudi Arabia: Findings and implications

    Article • Tropical Journal of Pharmaceutical Research, June 2025, African Journals Online (AJOL)

    Amanj Kurdi

  35. Exploring community pharmacy services in Gulf Cooperation Council countries: a scoping review

    Article • International Journal of Pharmacy Practice, June 2025, Oxford University Press (OUP)

    Amanj Kurdi

  36. Investigating the contribution of socio-economic position to ethnic inequalities in severe COVID-19 outcomes: population-based mediation analyses of national linked Scottish data

    Article • European Journal of Public Health, May 2025, Oxford University Press (OUP)

    Amanj Kurdi, Dr Evangelia Demou, Professor Colin R Simpson

  37. A retrospective clinical evaluation of the quality of antibiotic use in treating ear, nose and throat infections in ambulatory care setting of a teaching hospital in Ghana: findings and implications

    Article • BMC Infectious Diseases, April 2025, Springer Science + Business Media

    Amanj Kurdi

  38. Abstracts from the Pharmacy Education, Science and Practice Conference 2025 Part A

    Article • Journal of Pharmaceutical Policy and Practice, April 2025, Taylor & Francis

    Amanj Kurdi

  39. Knowledge, Attitudes, and Practices of Iraqi Parents Regarding Antibiotic Use in Children and the Implications

    Article • Antibiotics, April 2025, MDPI AG

    Amanj Kurdi

  40. The COVID-19 pandemic in children and young people during 2022–24: what new did we learn?

    Article • Journal of Global Health, April 2025, Edinburgh University Global Health Society

    Amanj Kurdi

  41. Replicating a COVID-19 study in a national England database to assess the generalisability of research with regional electronic health record data

    Article • BMJ Open, April 2025, BMJ

    Amanj Kurdi

  42. A population-based study of incident prescribing for hypercholesterolaemia and hypertension in Scotland: is the healthcare system recovering from the impact of COVID-19?

    Article • Current Medical Research and Opinion, March 2025, Taylor & Francis

    Amanj Kurdi

  43. Current access, availability and use of antibiotics in primary care among key low- and middle-income countries and the policy implications

    Article • Expert Review of Anti-infective Therapy, March 2025, Taylor & Francis

    Amanj Kurdi

  44. Impact of COVID-19 pandemic on the prescribing pattern of oral anticoagulants in the English primary care setting: a population-based segmented interrupted time series analysis of over 53 million individuals

    Article • Expert Review of Clinical Pharmacology, March 2025, Taylor & Francis

    Amanj Kurdi

  45. Use of sodium valproate and other antiseizure drug treatments in England and Wales: quantitative analysis of nationwide linked electronic health records

    Article • BMJ Medicine, December 2024, BMJ

    Amanj Kurdi

  46. Deriving and validating a risk prediction model for long COVID: a population-based, retrospective cohort study in Scotland

    Article • Journal of the Royal Society of Medicine, November 2024, SAGE Publications

    Amanj Kurdi

  47. ABSTRACTS of the 2024 ISPE Annual Meeting, Berlin, Germany, 24–28 August 2024

    Article • Pharmacoepidemiology and Drug Safety, November 2024, Wiley

    Amanj Kurdi

  48. Audit of antibiotic utilization patterns and practice for common eye infections at the ambulatory clinic of a teaching hospital in Ghana: Findings and implications

    Article • PLOS One, October 2024, PLOS

    Amanj Kurdi

  49. Promoting appropriate use of medicines in a healthcare system

    Article • September 2024, Wiley

    Amanj Kurdi

  50. Nephrotoxicity associated with aminoglycoside therapy in paediatrics: experiences from a leading referral hospital in Kenya

    Article • JAC-Antimicrobial Resistance, September 2024, Oxford University Press (OUP)

    Amanj Kurdi

  51. Selecting the most informative positive and negative controls for self-controlled case series (SCCS): Rationale, approach, and lessons from studies investigating the safety of COVID-19 vaccines

    Article • Journal of Global Health, August 2024, Edinburgh University Global Health Society

    Amanj Kurdi

  52. Impact of COVID-19 pandemic on the utilization and quality of antibiotic use in the primary care setting in England, March 2019–March 2023: a segmented interrupted time series analysis of over 53 million individuals

    Article • Expert Review of Anti-infective Therapy, July 2024, Taylor & Francis

    Amanj Kurdi

  53. Understanding Outcomes of COVID-19 Treatments including Antivirals and Antibodies across Scotland

    Article • npj Primary Care Respiratory Medicine, June 2024, Springer Science + Business Media

    Holly Tibble, Amanj Kurdi

  54. Impact of the COVID-19 pandemic on the utilisation and quality of antibiotic use in the Scottish primary care setting: a population-based segmented interrupted time-series analysis

    Article • Expert Review of Anti-infective Therapy, June 2024, Taylor & Francis

    Amanj Kurdi

  55. Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’

    Article • Expert Review of Anti-infective Therapy, April 2024, Taylor & Francis

    Amanj Kurdi

  56. Patterns of initial and first‐intensifying antidiabetic drug utilization among patients with type 2 diabetes mellitus in Scotland, 2010–2020: A retrospective population‐based cohort study

    Article • Diabetes Obesity and Metabolism, April 2024, Wiley

    Amanj Kurdi

  57. Managing infectious diarrhea among young children in community pharmacies in Saudi Arabia and the implications for AMR

    Article • Frontiers in Pediatrics, March 2024, Frontiers

    Amanj Kurdi

  58. A qualitative study exploring the challenges and enablers of pharmacists with a recent background in community pharmacy transitioning into primary care

    Article • International Journal of Clinical Pharmacy, March 2024, Springer Science + Business Media

    Amanj Kurdi

  59. Risk of winter hospitalisation and death from acute respiratory infections in Scotland: national retrospective cohort study

    Article • Journal of the Royal Society of Medicine, February 2024, SAGE Publications

    Amanj Kurdi, Professor Colin R Simpson

  60. Caveats in reporting of national vaccine uptake

    Article • Journal of Global Health, February 2024, Edinburgh University Global Health Society

    Amanj Kurdi, Professor Colin R Simpson

  61. Analysis of the use of antibiotics by AWaRe categories during the COVID-19 pandemic in hospitals across Scotland: a national population-based study

    Article • European Journal of Hospital Pharmacy, February 2024, BMJ

    Amanj Kurdi

  62. An Umbrella Review and Quality Assessment of Renin-Angiotensin System Drugs Use and COVID-19 Outcomes: What is the Quality of the Research Evidence?

    Article • Research in Social and Administrative Pharmacy, February 2024, Elsevier

    Amanj Kurdi

  63. Antimicrobial stewardship capacity and antibiotic utilisation practices in the Cape Coast Teaching Hospital, Ghana: A point prevalence survey study

    Article • PLOS One, January 2024, PLOS

    Amanj Kurdi

  64. Involving Patients and Clinicians in the Design of Wireframes for Cancer Medicines Electronic Patient Reported Outcome Measures in Clinical Care: Mixed Methods Study

    Article • JMIR Formative Research, December 2023, JMIR Publications Inc.

    Amanj Kurdi

  65. The Disruptive Impact of COVID-19 on the Utilization of Cancer Chemotherapy-Related Healthcare Assistance at the Principal Nationwide Referral Hospital in Kenya

    Article • Cureus, December 2023, Springer Science + Business Media

    Amanj Kurdi

  66. Selling antibiotics without prescriptions among community pharmacies and drug outlets: a simulated client study from Ghana

    Article • Expert Review of Anti-infective Therapy, November 2023, Taylor & Francis

    Amanj Kurdi

  67. Estimated indirect costs of haemodialysis versus peritoneal dialysis from a patients’ perspective at an Academic Hospital in Pretoria, South Africa

    Article • BMC Health Services Research, October 2023, Springer Science + Business Media

    Amanj Kurdi

  68. Quality of ethnicity data within Scottish health records and implications of misclassification for ethnic inequalities in severe COVID-19: a national linked data study

    Article • Journal of Public Health, October 2023, Oxford University Press (OUP)

    Amanj Kurdi, Holly Tibble, Professor Colin R Simpson

  69. Data Resource Profile: The Hospital Electronic Prescribing and Medicines Administration (HEPMA) National Data Collection in Scotland

    Article • International Journal for Population Data Science, October 2023, Swansea University

    Amanj Kurdi

  70. Current rates of purchasing of antibiotics without a prescription across sub-saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance

    Article • Expert Review of Anti-infective Therapy, September 2023, Taylor & Francis

    Amanj Kurdi, Prof. Joseph O Fadare, Godfrey Rwegerera

  71. Understanding and reporting odds ratios as rate-ratio estimates in case-control studies

    Article • Journal of Global Health, September 2023, Edinburgh University Global Health Society

    Amanj Kurdi, Professor Colin R Simpson

  72. Ethnic inequalities in positive SARS-CoV-2 tests, infection prognosis, COVID-19 hospitalisations and deaths: analysis of 2 years of a record linked national cohort study in Scotland

    Article • Journal of Epidemiology & Community Health, July 2023, BMJ

    Amanj Kurdi, Holly Tibble, Professor Colin R Simpson

  73. Assessment of the quality of antimicrobial prescribing among hospitalized patients in a teaching hospital in Ghana: findings and implications

    Article • Hospital Practice, July 2023, Taylor & Francis

    Amanj Kurdi

  74. Trends in the Cost of Medicines, Consultation Fees and Clinic Visits in Malaysia’s Private Primary Healthcare System: Employer Health Insurance Coverage

    Article • Journal of Multidisciplinary Healthcare, June 2023, Taylor & Francis

    Amanj Kurdi

  75. Airport based pharmacies; products, services and challenges essential for patients in a global travel landscape

    Article • Journal of the American Pharmacists Association, June 2023, Elsevier

    Amanj Kurdi

  76. Involving Patients and Clinicians in the Design of Wireframes for Cancer Medicines Electronic Patient Reported Outcome Measures in Clinical Care: Mixed Methods Study (Preprint)

    Article • April 2023, JMIR Publications Inc.

    Amanj Kurdi

  77. Corrigendum to “Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications”

    Article • BioMed Research International, April 2023, Hindawi Publishing Corporation

    Amanj Kurdi, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE

  78. Meta‐analysis of Factors Associated with Antidiabetic Drug Prescribing for Type 2 Diabetes Mellitus

    Article • European Journal of Clinical Investigation, April 2023, Wiley

    Amanj Kurdi

  79. Perceptions of and Preparedness for the Application of Pharmacoeconomics in Practice, among Final Year Bachelor of Pharmacy Students in South Africa: A National Cross-Sectional Study

    Article • Pharmacy, March 2023, MDPI AG

    Amanj Kurdi

  80. Risk Awareness and Demographic Characteristics Associated With the Use of Sexual Enhancement Supplements Among University Staff: A Cross-Sectional Study in the United Arab Emirates

    Article • American Journal of Men s Health, March 2023, SAGE Publications

    Amanj Kurdi

  81. Evaluation of duration of antibiotic therapy across hospitals in Scotland including the impact of COVID-19 pandemic: a segmented interrupted time series analysis

    Article • Expert Review of Anti-infective Therapy, February 2023, Taylor & Francis

    Amanj Kurdi

  82. Real-world effectiveness of systemic anticancer therapy for advanced melanoma in the west of Scotland from 2010 to 2018

    Article • Future Oncology, February 2023, Taylor & Francis

    Amanj Kurdi

  83. Evaluation of the antimicrobial prescribing pattern and the stewardship programs among COVID-19 hospitals in the capital city of Kurdistan-Northern Iraq: A multicenter point prevalence study

    Article • Passer Journal of Basic and Applied Sciences, January 2023, University of Garmian

    Amanj Kurdi

  84. The impact of the COVID-19 pandemic on cardiovascular disease prevention and management

    Article • Nature Reports Stem Cells, January 2023, Springer Science + Business Media

    Amanj Kurdi

  85. Shedding light on community pharmacist–directed point-of-care screening and education for patients with kidney stones: Implications and future research

    Article • Research in Social and Administrative Pharmacy, January 2023, Elsevier

    Amanj Kurdi

  86. Ongoing Efforts to Improve Antimicrobial Utilization in Hospitals among African Countries and Implications for the Future

    Article • Antibiotics, December 2022, MDPI AG

    Amanj Kurdi, Dr. Israel Abebrese Sefah, Prof. moyad jamal shahwan, Prof. Joseph O Fadare

  87. Assessing medication use patterns in patients hospitalised with COVID-19: a retrospective study

    Article • BMJ Open, December 2022, BMJ

    Amanj Kurdi, Holly Tibble

  88. Uptake of COVID-19 treatments in Scotland

    Article • The Lancet, December 2022, Elsevier

    Holly Tibble, Amanj Kurdi

  89. Effects of the COVID-19 pandemic on secondary care for cardiovascular disease in the UK: an electronic health record analysis across three countries

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, November 2022, Oxford University Press (OUP)

    Amanj Kurdi

  90. Access to non-prescription medicines via vending machines: key considerations to help transfer the self-care concept to the next generation while managing safety risks

    Article • Journal of Pharmaceutical Health Services Research, November 2022, Oxford University Press (OUP)

    Amanj Kurdi

  91. An umbrella review and meta‐analysis of renin‐angiotensin system drugs use and COVID ‐19 outcomes

    Article • European Journal of Clinical Investigation, October 2022, Wiley

    Amanj Kurdi

  92. Appropriateness of surgical antimicrobial prophylaxis in a teaching hospital in Ghana: findings and implications

    Article • JAC-Antimicrobial Resistance, September 2022, Oxford University Press (OUP)

    Amanj Kurdi, Dr. Israel Abebrese Sefah

  93. ABSTRACTS of ICPE 2022, the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE), Copenhagen, Denmark, 26–28 August, 2022

    Article • Pharmacoepidemiology and Drug Safety, September 2022, Wiley

    Amanj Kurdi

  94. Tackling antimicrobial resistance across sub-Saharan Africa: current challenges and implications for the future

    Article • Expert Opinion on Drug Safety, August 2022, Taylor & Francis

    Amanj Kurdi, Prof. Joseph O Fadare

  95. A national, multicentre web-based point prevalence survey of antimicrobial use in community healthcare centres across South Africa and the implications

    Article • Hospital Practice, August 2022, Taylor & Francis

    Amanj Kurdi

  96. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis

    Article • PLOS One, August 2022, PLOS

    Amanj Kurdi, Faisal Alshaikh

  97. Acceptability and Willingness of UAE Residents to Use OTC Vending Machines to Deliver Self-Testing Kits for COVID-19 and the Implications

    Article • Journal of Multidisciplinary Healthcare, August 2022, Taylor & Francis

    Amanj Kurdi

  98. Impact of Parental Knowledge and Beliefs on HPV Vaccine Hesitancy in Kenya—Findings and Implications

    Article • Vaccines, July 2022, MDPI AG

    Amanj Kurdi

  99. Characteristics and Management of Children With Suspected COVID-19 Admitted to Hospitals in India: Implications for Future Care

    Article • Cureus, July 2022, Cureus, Inc.

    Amanj Kurdi

  100. Regional variation in longitudinal trajectories of primary care opioids prescribing across Health Boards in Scotland: a population-based study

    Article • Expert Review of Clinical Pharmacology, July 2022, Taylor & Francis

    Amanj Kurdi, Dr Li-Chia Chen

  101. Assessing knowledge, attitude and practice of community pharmacists on the pain management and implications in UAE children

    Article • Pharmacy Practice, July 2022, JCFCorp SG PTE LTD

    Amanj Kurdi

  102. Development and Validation of a Tool to Improve Community Pharmacists’ Surveillance Role in the Safe Dispensing of Herbal Supplements

    Article • Frontiers in Pharmacology, July 2022, Frontiers

    Amanj Kurdi

  103. Evaluation of antibiotic prescribing for ambulatory patients seeking primary dental care services in a public hospital in Ghana: a clinical audit study

    Article • JAC-Antimicrobial Resistance, July 2022, Oxford University Press (OUP)

    Amanj Kurdi, Prof. Joseph O Fadare

  104. COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records

    Article • The Lancet Digital Health, July 2022, Elsevier

    Amanj Kurdi, Dr Mark A Green

  105. What patient assessment skills do pharmacist independent prescribers require to prescribe immunomodulators in myeloma?

    Article • Journal of Oncology Pharmacy Practice, June 2022, SAGE Publications

    Amanj Kurdi

  106. The impact of the COVID-19 pandemic lockdown measures on the prescribing trends and utilization of opioids in the English primary care setting: segmented-liner regression analysis

    Article • Expert Review of Clinical Pharmacology, June 2022, Taylor & Francis

    Amanj Kurdi

  107. Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries

    Article • Frontiers in Pharmacology, June 2022, Frontiers

    Amanj Kurdi, Guenka Petrova

  108. An umbrella review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 outcomes: what do we know so far?

    Article • May 2022, Authorea, Inc.

    Amanj Kurdi

  109. Assessing the management of patients with type 2 diabetes in Bangladesh during pre- and post-COVID-19 era and the implications: A pilot study

    Article • Journal of Applied Biology & Biotechnology, May 2022, Journal of Applied Pharmaceutical Science

    Amanj Kurdi

  110. Top unresolved ethical challenges and dilemmas faced by community pharmacists in providing pharmaceutical care: Drawing the line between ethical challenges and the quality of the pharmaceutical care

    Article • Research in Social and Administrative Pharmacy, May 2022, Elsevier

    Amanj Kurdi, Prof. moyad jamal shahwan

  111. An umbrella review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 outcomes: what do we know so far?

    Article • International Journal of Pharmacy Practice, April 2022, Oxford University Press (OUP)

    Amanj Kurdi

  112. Obesity association with antidiabetic drugs’ prescription among patients with type 2 diabetes mellitus: a systematic review and meta-analysis

    Article • International Journal of Pharmacy Practice, April 2022, Oxford University Press (OUP)

    Amanj Kurdi

  113. The impact of the COVID-19 pandemic lockdown measures on the prescribing trends and utilisation of opioids in the English primary care setting: a segmented-linear regression analysis

    Article • International Journal of Pharmacy Practice, April 2022, Oxford University Press (OUP)

    Amanj Kurdi

  114. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: a systematic review and meta-analysis

    Article • International Journal of Pharmacy Practice, April 2022, Oxford University Press (OUP)

    Amanj Kurdi

  115. An umbrella review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 outcomes: what do we know so far?

    Article • March 2022, Cold Spring Harbor Laboratory Press

    Amanj Kurdi

  116. Biosimilars are essential for sustainable healthcare systems; however, key challenges remain as seen with long-acting insulin analogues

    Article • Journal of Applied Biology & Biotechnology, March 2022, Journal of Applied Pharmaceutical Science

    Amanj Kurdi

  117. Barriers and facilitators of adherence to antiretroviral treatment at a public health facility in Ghana: a mixed method study

    Article • Hospital Practice, February 2022, Taylor & Francis

    Amanj Kurdi

  118. Management of Children Admitted to Hospitals across Bangladesh with Suspected or Confirmed COVID-19 and the Implications for the Future: A Nationwide Cross-Sectional Study

    Article • Antibiotics, January 2022, MDPI AG

    Amanj Kurdi, Professor Dr Mainul Haque

  119. Access to community pharmacy services for people with disabilities: Barriers, challenges, and opportunities

    Article • Research in Social and Administrative Pharmacy, January 2022, Elsevier

    Amanj Kurdi, Prof. moyad jamal shahwan

  120. Opportunities and challenges when using record linkage of routinely collected electronic health care data to evaluate outcomes of systemic anti-cancer treatment in clinical practice

    Article • Health Informatics Journal, January 2022, SAGE Publications

    Amanj Kurdi

  121. Patients' knowledge and practice on disposal of medicines kept in households in South Africa: Findings and implications

    Article • Journal of Research in Pharmacy Practice, January 2022, Medknow

    Amanj Kurdi

  122. Using Administrative Data from Public Health and Drug Programs

    Article • January 2022, Springer Science + Business Media

    Amanj Kurdi

  123. Challenges and Innovations Brought about by the COVID-19 Pandemic Regarding Medical and Pharmacy Education Especially in Africa and Implications for the Future

    Article • Healthcare, December 2021, MDPI AG

    Amanj Kurdi, Professor Dr Mainul Haque, Prof. Joseph O Fadare, Godfrey Rwegerera

  124. What matters to patients and clinicians when discussing the impact of cancer medicines on health-related quality of life? Consensus-based mixed methods approach in prostate cancer

    Article • Supportive Care in Cancer, December 2021, Springer Science + Business Media

    Amanj Kurdi

  125. Key issues surrounding the management of non-communicable diseases including the management of diabetes post COVID-19 among developing countries with a specific focus on Bangladesh

    Article • Journal of Applied Biology & Biotechnology, December 2021, Journal of Applied Pharmaceutical Science

    Amanj Kurdi

  126. A national, multicentre web-based point prevalence survey of antimicrobial use and quality indices among hospitalised paediatric patients across South Africa

    Article • Journal of Global Antimicrobial Resistance, December 2021, Elsevier

    Amanj Kurdi

  127. Retrospective cohort study to evaluate medication use in patients hospitalised with COVID-19 in Scotland: protocol for a national observational study

    Article • BMJ Open, November 2021, BMJ

    Amanj Kurdi, Professor Colin R Simpson

  128. Use of Sedative‐Hypnotic Medications and Risk of Dementia: A Systematic Review and Meta‐Analysis

    Article • British Journal of Clinical Pharmacology, October 2021, Wiley

    Amanj Kurdi

  129. Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications

    Article • BioMed Research International, October 2021, Hindawi Publishing Corporation

    Amanj Kurdi, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Guenka Petrova

  130. Frequency and determinants of domestic violence against Iranian women during the COVID-19 pandemic: a national cross-sectional survey

    Article • BMC Public Health, September 2021, Springer Science + Business Media

    Amanj Kurdi

  131. Opioids and Gabapentinoids Utilisation and Their Related-Mortality Trends in the United Kingdom Primary Care Setting, 2010–2019: A Cross-National, Population-Based Comparison Study

    Article • Frontiers in Pharmacology, September 2021, Frontiers

    Amanj Kurdi

  132. Pilot Study on the Current Management of Children with COVID-19 In Hospitals in Bangladesh; Findings and Implications

    Article • Bangladesh Journal of Medical Science, September 2021, Bangladesh Journals Online (BanglaJOL)

    Amanj Kurdi

  133. Validity of Pneumonia Severity Assessment Scores in Africa and South Asia: A Systematic Review and Meta-Analysis

    Article • Healthcare, September 2021, MDPI AG

    Amanj Kurdi

  134. Antimicrobial Stewardship Activities in Public Healthcare Facilities in South Africa: A Baseline for Future Direction

    Article • Antibiotics, August 2021, MDPI AG

    Amanj Kurdi

  135. Health systems, population and patient challenges for achieving universal health coverage for hypertension in Ghana

    Article • Health Policy and Planning, July 2021, Oxford University Press (OUP)

    Amanj Kurdi

  136. Correction to: Polypharmacy definition and prevalence in heart failure: a systematic review

    Article • Heart Failure Reviews, July 2021, Springer Science + Business Media

    Amanj Kurdi

  137. Evidence-based public policy making for medicines across countries: findings and implications for the future

    Article • Journal of Comparative Effectiveness Research, July 2021, Future Medicine

    Amanj Kurdi, Prof. Joseph O Fadare

  138. Polypharmacy definition and prevalence in heart failure: a systematic review

    Article • Heart Failure Reviews, July 2021, Springer Science + Business Media

    Amanj Kurdi

  139. Current utilisation patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future

    Article • Current Medical Research and Opinion, June 2021, Taylor & Francis

    Amanj Kurdi, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Professor Dr Mainul Haque

  140. The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future

    Article • Frontiers in Public Health, June 2021, Frontiers

    Amanj Kurdi, Professor Mihajlo (Michael) Jakovljevic MD, PhD, MAE, Guenka Petrova, Dr. Israel Abebrese Sefah, Godfrey Rwegerera

  141. A multicentre point prevalence study of antibiotics utilization in hospitalized patients in an urban secondary and a tertiary healthcare facilities in Nigeria: findings and implications

    Article • Expert Review of Anti-infective Therapy, June 2021, Taylor & Francis

    Amanj Kurdi

  142. Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries

    Article • Life, June 2021, MDPI AG

    Amanj Kurdi, Professor Dr Mainul Haque, Dr. Israel Abebrese Sefah

  143. Activities in Namibia to Limit the Prevalence and Mortality from COVID-19 Including Community Pharmacy Activities and the Implications

    Article • Scholars Academic Journal of Pharmacy, May 2021, SASPR Edu International Pvt. Ltd

    Amanj Kurdi

  144. Assessment of adherence to pneumonia guidelines and its determinants in an ambulatory care clinic in Ghana: findings and implications for the future

    Article • JAC-Antimicrobial Resistance, April 2021, Oxford University Press (OUP)

    Amanj Kurdi

  145. Influence of pharmaceutical services organization on the availability of essential medicines in a public health system

    Article • Journal of Comparative Effectiveness Research, March 2021, Future Medicine

    Amanj Kurdi

  146. A point prevalence survey of antimicrobial utilisation patterns and quality indices amongst hospitals in South Africa; findings and implications

    Article • Expert Review of Anti-infective Therapy, March 2021, Taylor & Francis

    Amanj Kurdi

  147. Development of a web-based application to improve data collection of antimicrobial utilization in the public health care system in South Africa

    Article • Hospital Practice, March 2021, Taylor & Francis

    Amanj Kurdi

  148. Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications

    Article • Expert Review of Pharmacoeconomics & Outcomes Research, February 2021, Taylor & Francis

    Amanj Kurdi, Guenka Petrova

  149. Key Issues Surrounding Appropriate Antibiotic Use for Prevention of Surgical Site Infections in Low- and Middle-Income Countries: A Narrative Review and the Implications

    Article • International Journal of General Medicine, February 2021, Taylor & Francis

    Amanj Kurdi

  150. Utilisation, Availability and Price Changes of Medicines and Protection Equipment for COVID-19 Among Selected Regions in India: Findings and Implications

    Article • Frontiers in Pharmacology, January 2021, Frontiers

    Amanj Kurdi, Dr. Israel Abebrese Sefah

  151. Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications

    Article • Frontiers in Pharmacology, January 2021, Frontiers

    Amanj Kurdi, Dr. Israel Abebrese Sefah

  152. Changes in availability, utilization, and prices of medicines and protection equipment for COVID-19 in an Urban population of Northern Nigeria

    Article • Journal of Research in Pharmacy Practice, January 2021, Medknow

    Amanj Kurdi

  153. Prevalence rate of spontaneously reported adverse events and determinants of serious adverse events amongst three outpatient care settings in ghana: findings and implications

    Article • Advances in Human Biology, January 2021, Medknow

    Amanj Kurdi

  154. COVID-19, health care and self-medication issues in resource-limited settings: Findings and implications based on experiences in Ghana

    Article • Advances in Human Biology, January 2021, Medknow

    Amanj Kurdi

  155. Health-Care professionals' knowledge and practice regarding disposal of medicines in primary health-care facilities in South Africa: Impact and implications

    Article • Journal of Research in Pharmacy Practice, January 2021, Medknow

    Amanj Kurdi

  156. The prevalence of medication errors among nursing students: A systematic and meta-analysis study

    Article • International Journal of Preventive Medicine, January 2021, Medknow

    Amanj Kurdi

  157. Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future

    Article • Frontiers in Public Health, December 2020, Frontiers

    Amanj Kurdi, Dr. Israel Abebrese Sefah

  158. A systematic review and meta‐analysis of the use of renin‐angiotensin system drugs and COVID‐19 clinical outcomes: What is the evidence so far?

    Article • Pharmacology Research & Perspectives, October 2020, Wiley

    Amanj Kurdi

  159. Supporting antimicrobial stewardship in Ghana: evaluation of the impact of training on knowledge and attitudes of healthcare professionals in two hospitals

    Article • JAC-Antimicrobial Resistance, October 2020, Oxford University Press (OUP)

    Amanj Kurdi

  160. A multicentre point prevalence survey of hospital antibiotic prescribing and quality indices in the Kurdistan Regional Government of Northern Iraq: The need for urgent action

    Article • Expert Review of Anti-infective Therapy, October 2020, Taylor & Francis

    Amanj Kurdi

  161. Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future

    Article • Frontiers in Pharmacology, September 2020, Frontiers

    Amanj Kurdi, Dr Wafaa M. Rashed, Dr. Israel Abebrese Sefah, Prof. Joseph O Fadare, Godfrey Rwegerera

  162. Supporting global antimicrobial stewardship: antibiotic prophylaxis for the prevention of surgical site infection in low- and middle-income countries (LMICs): a scoping review and meta-analysis

    Article • JAC-Antimicrobial Resistance, September 2020, Oxford University Press (OUP)

    Amanj Kurdi

  163. A systematic review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 clinical outcomes: What is the evidence so far?

    Article • August 2020, Authorea, Inc.

    Amanj Kurdi

  164. Compliance with South Africa’s Antimicrobial Resistance National Strategy Framework: are we there yet?

    Article • Journal of Chemotherapy, July 2020, Taylor & Francis

    Amanj Kurdi

  165. Availability and price changes of potential medicines and equipment for the prevention and treatment of COVID-19 among pharmacy and drug stores in Bangladesh; findings and implications

    Article • Bangladesh Journal of Medical Science, July 2020, Bangladesh Journals Online (BanglaJOL)

    Amanj Kurdi, Dr. Israel Abebrese Sefah

  166. Lessons from the failure of implementing the ‘Better Care Better Value’ prescribing indicator for renin–angiotensin system drugs in England: a qualitative study of general practitioners’ perceptions using behavioural change framework

    Article • BMJ Open, June 2020, BMJ

    Amanj Kurdi, Dr Li-Chia Chen

  167. Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future

    Article • Hospital Practice, May 2020, Taylor & Francis

    Amanj Kurdi, Dr. Israel Abebrese Sefah, Prof. Joseph O Fadare, Godfrey Rwegerera

  168. Evaluation of the prescribing decision support system Synonyms in a primary care setting: a mixed‐method study

    Article • International Journal of Pharmacy Practice, May 2020, Wiley

    Amanj Kurdi

  169. Real‐world evaluation of the impact of statin intensity on adherence and persistence to therapy: A Scottish population‐based study

    Article • British Journal of Clinical Pharmacology, April 2020, Wiley

    Amanj Kurdi

  170. Use of record linkage to evaluate treatment outcomes and trial eligibility in a real‐world metastatic prostate cancer population in Scotland

    Article • Pharmacoepidemiology and Drug Safety, April 2020, Wiley

    Amanj Kurdi

  171. Translation and Validation of the Farsi Version of the Pain Management Self-Efficacy Questionnaire

    Article • Journal of Pain Research, April 2020, Taylor & Francis

    Amanj Kurdi

  172. Review of Ongoing Activities and Challenges to Improve the Care of Patients With Type 2 Diabetes Across Africa and the Implications for the Future

    Article • Frontiers in Pharmacology, March 2020, Frontiers

    Amanj Kurdi, Dr. Israel Abebrese Sefah, Prof. Joseph O Fadare

  173. Antimicrobial point prevalence surveys in two Ghanaian hospitals: opportunities for antimicrobial stewardship

    Article • JAC-Antimicrobial Resistance, February 2020, Oxford University Press (OUP)

    Amanj Kurdi

  174. Evaluation of the clinical practice of aminoglycoside use in paediatric patients in Kenya: findings and implications for lower-middle income countries

    Article • JAC-Antimicrobial Resistance, January 2020, Oxford University Press (OUP)

    Amanj Kurdi

  175. Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries

    Article • Expert Review of Pharmacoeconomics & Outcomes Research, January 2020, Taylor & Francis

    Amanj Kurdi, Dr. Israel Abebrese Sefah, Prof. Joseph O Fadare, Godfrey Rwegerera

  176. A Systematic Review and Meta-Analysis of the Use of Renin-Angiotensin System Blockers and COVID-19 Outcomes: What is the Evidence so Far and the Implications?

    Article • SSRN Electronic Journal, January 2020, Elsevier

    Amanj Kurdi

  177. Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future

    Article • Current Medical Research and Opinion, December 2019, Taylor & Francis

    Amanj Kurdi, Professor Dr Mainul Haque, Dr. Israel Abebrese Sefah, Prof. Joseph O Fadare

  178. Proactive risk assessment of vincristine use process in a teaching and referral hospital in Kenya and the implications

    Article • Journal of Oncology Pharmacy Practice, September 2019, SAGE Publications

    Amanj Kurdi

  179. Pricing of oral generic cancer medicines in 25 European countries; fi ndings and implications

    Article • Generics and Biosimilars Initiative Journal, June 2019, Pro Pharma Communications International

    Amanj Kurdi, Guenka Petrova

  180. Prescribing trends of inhaler treatments for asthma and chronic obstructive pulmonary disease within a resource-constrained environment in the Scottish national health service: findings and implications

    Article • Expert Review of Respiratory Medicine, June 2019, Taylor & Francis

    Amanj Kurdi, Prof Alec Morton

  181. Clinical and economic implications of therapeutic switching of angiotensin receptor blockers to angiotensin-converting enzyme inhibitors

    Article • Journal of Hypertension, June 2019, Wolters Kluwer Health

    Amanj Kurdi, Dr Li-Chia Chen

  182. Prevalence of metabolic syndrome among Iranian women with polycystic ovary syndrome: A systematic review and meta-analysis

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, May 2019, Elsevier

    Amanj Kurdi

  183. Adverse effects of chemotherapy and their management in Pediatric patients with Non-Hodgkin’s Lymphoma in Kenya: A descriptive, situation analysis study

    Article • Expert Review of Anticancer Therapy, April 2019, Taylor & Francis

    Amanj Kurdi, Linda Opanga

  184. Ongoing initiatives within the Scottish National Health Service to affect the prescribing of selective serotonin reuptake inhibitors and their influence

    Article • Journal of Comparative Effectiveness Research, April 2019, Future Medicine

    Amanj Kurdi

  185. Feasibility of using point prevalence surveys to assess antimicrobial utilisation in public hospitals in South Africa: a pilot study and implications

    Article • Hospital Practice, March 2019, Taylor & Francis

    Amanj Kurdi, Nokuthula Dlamini

  186. A Systematic Review and Meta-Analysis of Health Literacy in the Iranian Population: Findings and Implications

    Article • Shiraz E-Medical Journal, March 2019, Kowsar Medical Institute

    Amanj Kurdi

  187. Prevalence of depression among Iranian patients with rheumatoid arthritis: a systematic review and meta-analysis

    Article • Open Access Rheumatology Research and Reviews, February 2019, Dove Medical Press

    Reza Ghanei Gheshlagh, Sahar Dalvand, Amanj Kurdi

  188. Health-related quality of life in Iranian patients with type 2 diabetes: An updated meta-analysis

    Article • Diabetes & Metabolic Syndrome Clinical Research & Reviews, January 2019, Elsevier

    Amanj Kurdi

  189. The use of probiotics as a supplementary therapy in the treatment of patients with asthma: a pilot study and implications

    Article • Clinics, January 2019, Fundacao Faculdade de Medicina

    Amanj Kurdi

  190. Antibiotic prescribing patterns at a leading referral hospital in Kenya: A point prevalence survey

    Article • Journal of Research in Pharmacy Practice, January 2019, Medknow

    Amanj Kurdi

  191. Clinical and Financial Implications of Medicine Consumption Patterns at a Leading Referral Hospital in Kenya to Guide Future Planning of Care

    Article • Frontiers in Pharmacology, December 2018, Frontiers

    Amanj Kurdi

  192. Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets

    Article • Frontiers in Public Health, December 2018, Frontiers

    Amanj Kurdi, Guenka Petrova, Prof. Joseph O Fadare

  193. Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis

    Article • BioDrugs, November 2018, Springer Science + Business Media

    Amanj Kurdi

  194. Antibiotic consumption and antimicrobial resistance in Poland; findings and implications

    Article • Antimicrobial Resistance and Infection Control, November 2018, Springer Science + Business Media

    Amanj Kurdi

  195. Prevalence of poststroke depression in Iranian patients: a systematic review and meta-analysis

    Article • November 2018, Dove Medical Press

    Amanj Kurdi, Reza Ghanei Gheshlagh, Sahar Dalvand

  196. Comparison of Zidovudine and Tenofovir Based Regimens With Regard to Health-Related Quality of Life and Prevalence of Symptoms in HIV Patients in a Kenyan Referral Hospital

    Article • Frontiers in Pharmacology, October 2018, Frontiers

    Amanj Kurdi

  197. Trends in the prescribing of antipsychotic medicines in Pakistan: implications for the future

    Article • Current Medical Research and Opinion, September 2018, Taylor & Francis

    Amanj Kurdi

  198. Adequacy of Dialysis in Iranian Patients Undergoing Hemodialysis: A Systematic Review and Meta-Analysis

    Article • Nephro-Urology Monthly, September 2018, Kowsar Medical Institute

    Amanj Kurdi

  199. Validity of World Health Organisation prescribing indicators in Namibia’s primary healthcare: findings and implications

    Article • International Journal for Quality in Health Care, August 2018, Oxford University Press (OUP)

    Amanj Kurdi

  200. Ongoing activities to optimize the quality and efficiency of lipid-lowering agents in the Scottish national health service: influence and implications

    Article • Expert Review of Pharmacoeconomics & Outcomes Research, August 2018, Taylor & Francis

    Amanj Kurdi, Prof Alec Morton

  201. Abstract

    Article • Pharmacoepidemiology and Drug Safety, August 2018, Wiley

    Amanj Kurdi, Dr Prasad S Nishtala, Dr Li-Chia Chen

  202. Prevalence of depression among Iranian patients under hemodialysis: a systematic review and meta-analysis

    Article • Journal of Nephropathology, July 2018, International Society for Phytocosmetic Scicences

    Amanj Kurdi

  203. Evaluation of antihypertensive adherence and its determinants at primary healthcare facilities in rural South Africa

    Article • Journal of Comparative Effectiveness Research, July 2018, Future Medicine

    Amanj Kurdi

  204. Pilot study assessing the direct medical cost of treating patients with cancer in Kenya; findings and implications for the future

    Article • Journal of Medical Economics, June 2018, Taylor & Francis

    Amanj Kurdi

  205. Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications

    Article • Frontiers in Pharmacology, May 2018, Frontiers

    Amanj Kurdi

  206. Point prevalence survey of antibiotic use and resistance at a referral hospital in Kenya: findings and implications

    Article • Hospital Practice, April 2018, Taylor & Francis

    Amanj Kurdi

  207. Statin use in Brazil: findings and implications

    Article • Current Medical Research and Opinion, April 2018, Taylor & Francis

    Amanj Kurdi

  208. Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications

    Article • Hospital Practice, February 2018, Taylor & Francis

    Prof. Joseph O Fadare, Dr Olufemi O DESALU, Amanj Kurdi

  209. Ongoing initiatives in Azerbaijan to improve the use of antibiotics; findings and implications

    Article • Expert Review of Anti-infective Therapy, December 2017, Taylor & Francis

    Amanj Kurdi

  210. Assessing Adherence to Antihypertensive Therapy in Primary Health Care in Namibia: Findings and Implications

    Article • Cardiovascular Drugs and Therapy, October 2017, Springer Science + Business Media

    Amanj Kurdi

  211. Prescription patterns and adequacy of blood pressure control among adult hypertensive patients in Kenya; findings and implications

    Article • Expert Review of Clinical Pharmacology, September 2017, Taylor & Francis

    Amanj Kurdi

  212. Exploring factors associated with patients’ adherence to antihypertensive drugs among people with primary hypertension in the United Kingdom

    Article • Journal of Hypertension, September 2017, Wolters Kluwer Health

    Dr Li-Chia Chen, Dr Li-Chia Chen, Amanj Kurdi

  213. Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia’s national referral hospital: a pilot study and the implications

    Article • Expert Review of Anti-infective Therapy, May 2017, Taylor & Francis

    Amanj Kurdi, Dan Kibuule

  214. Initiatives to increase the prescribing of low cost generics; the case of Scotland in the international context

    Article • Medical Research Archives, January 2017, Knowledge Enterprise Journals

    Amanj Kurdi

  215. The impact of the ‘Better Care Better Value’ prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: longitudinal quasi-experimental d...

    Article • BMC Health Services Research, June 2015, Springer Science + Business Media

    Dr Li-Chia Chen, Amanj Kurdi